Psychedelic Medicine and Interventional Psychiatry

The purpose of this course is to provide medical and mental health professionals with the knowledge and skills necessary to effectively treat mental disorders using emerging psychedelic and interventional techniques. In addition, members of the public may use this course to enhance their personal knowledge of the subject matter presented.

Upon completion of this course, you should be able to:

Outline factors that have contributed to the rise in interest in psychedelic and interventional psychiatry. Define terms related to the discussion of psychedelic and interventional psychiatry. Discuss the history of psychedelics in medical care. Evaluate factors that may impact the provision of psychedelic or interventional psychiatry techniques, including stigma, setting, and culture. Outline the role of psilocybin and ketamine in psychiatric care. Describe how MDMA and ibogaine may impact mental health. Review the clinical effects of kratom, LSD, and mescaline. Discuss the potential clinical role of nitrous oxide, ayahuasca, and dimethyltryptamine (DMT). Describe how psychedelics may be incorporated into the treatment of mental health disorders, including treatment-resistant depression, post-traumatic stress disorder, and substance use disorders. Identify interventional approaches that may be used in the treatment of mental health disorders.

This 10-hour continuing education course is available for download for professional development; if continuing education credit is desired, please see instructions included in eBook.